BioXmark liquid fiducial to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial
Completed
- Conditions
- rectal tumor10017990
- Registration Number
- NL-OMON47645
- Lead Sponsor
- MAASTRO clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
* patients with histological or cytological proven rectal cancer, treated with long course external beam radiotherapy
* Age 18 year or older
* have given written informed consent
Exclusion Criteria
* iodine allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Positional stability of BioXmark liquid fiducial markers during the treatment<br /><br>course</p><br>
- Secondary Outcome Measures
Name Time Method